StockData
Cerus Corp logo

Cerus Corp (CERS) stock

CERSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 6/3027% below fair value
$1.94−0.18 (-8.49%)

Close on Nov 12, 2026Market cap $390.96MP/E –Yield –

Earnings

Cerus's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 1, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
$64.00M
+6.3% on a year earlier
EPS, Q3 FY2026
$0.00
$0.00 a year earlier
Latest guidance
Raised
Nov 2, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of Cerus's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 1, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 2, 2026after the close$64.00M+6.3%$0.00Release
Q2 FY2026ended Jun 30, 2026Jul 30, 2026during market hours$63.30M+5.3%-$0.01Release
Q1 FY2026ended Mar 31, 2026Apr 30, 2026during market hours$59.90M+22.5%-$0.01Release
Q4 FY2025ended Dec 31, 2025Mar 2, 2026during market hours$64.60M+13.8%-$0.01Release
Q3 FY2025ended Sep 30, 2025Nov 6, 2025during market hours$60.20M+18.8%$0.00Release
Q2 FY2025ended Jun 30, 2025Aug 5, 2025during market hours$60.10M+19.0%–Release
Q1 FY2025ended Mar 31, 2025May 1, 2025during market hours$48.90M+12.7%-$0.04Release
Q4 FY2024ended Dec 31, 2024Feb 20, 2025during market hours$56.75M+6.4%-$0.01Release
Q3 FY2024ended Sep 30, 2024Oct 30, 2024during market hours$50.66M+7.1%-$0.02Release
Q2 FY2024ended Jun 30, 2024Aug 1, 2024during market hours$50.52M+5.9%-$0.03Release
Q1 FY2024ended Mar 31, 2024May 2, 2024during market hours$43.40M+12.7%-$0.05Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Cerus's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
product revenueFY2026$229.00M – $231.00M$224.00M – $228.00MRaisedNov 2, 2026
product revenueFY2026$229.00M – $231.00M$227.00M – $231.00MRaisedJul 30, 2026
product revenue growthFY2026+11% – +12%+10% – +12%RaisedJul 30, 2026

Guidance vs results

The last range Cerus gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Revenue$202.00M – $204.00M$233.80MΣ4QAbove range
FY2025Revenue growth+12% – +13%+16.13%Σ4QAbove range
Q1 FY2025Revenue growth+10% – +15%+12.69%Within range

Guidance history

Every forecast Cerus put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 2, 2026product revenueFY2026$229.00M – $231.00MRaised
Nov 2, 2026IFC revenueFY2026$23.00M – $25.00MLowered
Jul 30, 2026product revenue growthFY2026+11% – +12%Raised
Jul 30, 2026product revenueFY2026$229.00M – $231.00MRaised
Jul 30, 2026IFC revenueFY2026$23.00M – $25.00MLowered
Apr 30, 2026product revenue growthFY2026+10% – +12%Lowered
Apr 30, 2026product revenueFY2026$227.00M – $231.00MRaised
Apr 30, 2026IFC revenueFY2026$22.00M – $24.00MLowered
Mar 2, 2026product revenueFY2026$224.00M – $228.00MNew
Mar 2, 2026IFC revenueFY2026$20.00M – $22.00MLowered
Jan 12, 2026year-over-year growthFY2026+9% – +11%New
Jan 12, 2026year-over-year growthFY2026+20% – +30%Raised
Jan 12, 2026full-year 2026 product revenueFY2026$224.00M – $228.00MNew
Jan 12, 2026full-year 2026 IFC revenueFY2026$20.00M – $22.00MLowered
Nov 6, 2025product revenue growthFY2025+12% – +13%New
Nov 6, 2025product revenueFY2025$202.00M – $204.00MNew
Nov 6, 2025IFC revenueFY2025$16.00M – $17.00MLowered
Aug 5, 2025product revenueFY2025$200.00M – $203.00MRaised
Aug 5, 2025IFC guidanceFY2025$16.00M – $18.00MLowered
May 1, 2025product revenue growthFY2025+8% – +11%Reaffirmed

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Cerus filed with the SEC as exhibits to Form 8-K or 6-K

  1. Cerus Corporation Announces Third Quarter 2026 Financial Results
    Results
  2. Cerus Corporation Announces Second Quarter 2026 Financial Results
    Results
  3. Cerus Corporation Announces First Quarter 2026 Financial Results
    Results
  4. Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results
    Results
  5. Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook
    Results
  6. Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance
    Results
  7. Cerus Corporation Announces Second Quarter 2025 Financial Results
    Results
  8. Cerus Corporation Announces First Quarter 2025 Financial Results
    Results
  9. Cerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial Results
    Results
  10. Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business Update
    Results
  11. Cerus Corporation Announces Third Quarter 2024 Financial Results
    Results
  12. Cerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and Europe
    News
  13. Cerus Corporation Announces Second Quarter 2024 Financial Results and Increases Full-Year 2024 Product Revenue Guidance Range
    Results
  14. Cerus Corporation Announces First Quarter 2024 Financial Results
    Results
  15. Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients
    News

See a number that looks wrong?